Clinical Trial Update: Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment [NA]

View source ↗

Summary

This clinical trial update notes an active-not-recruiting study evaluating a combination of targeted therapy with tislelizumab and hepatic arterial infusion che…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• HAIC (hepatic artery infusion chemotherapy)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Peking University | Conditions: Liver Metastasis Colon Cancer, ctDNA Genotype | NA | Status: ACTIVE_NOT_RECRUITING